Skip to content

Inspection Record

SAFC Pharma Carlsbad — FDA 483 Findings

US FDAInspected 2017-06-22Published 2026-10-26 5 findingsContamination controlMaterial and supplier controlEquipment and facilityAseptic processing and sterility assuranceOther quality system

Inspectors Arie C. MenachemThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination ofthe (©) @product.

2Material and supplier control

Establishment ofthe reliability of the component supplier's report of analyses is deficient in that the test results are not appropriately validated at appropriate intervals.

3Equipment and facility

Routine calibration of equipment is not performed according to a written program designed to assure proper performance.

4Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of pi products purporting to be sterile are not established, written, or followed.

5Other quality system

Written procedures are not approved by the appropriate organizational units.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

SAFC Pharma Carlsbad company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.